GATC Health President Dr. Rahul Gupta to Headline Semafor’s Future of Health Forum, Engaging Investors and Policy Leaders on Healthcare Innovation

Washington, DC — November 17, 2025 — GATC Health proudly announces that its President, Dr. Rahul Gupta, will deliver headline remarks at Semafor’s The Future of Health Forum: Changing the Script on American Healthcare event, an exclusive, invite-only summit held on Tuesday, November 18th, convening the nation’s top health, investment, and policy influencers. The forum addresses the escalating crises in U.S. healthcare—rising costs, cuts to community services, workforce shortages, and shifting federal policy—that have left more Americans struggling to afford and access quality care. 

This year’s event offers a powerful platform for GATC Health to demonstrate leadership at the intersection of health and innovation. The forum audience—composed of senior executives, key healthcare investors, policy stakeholders, and the financial press—provides unique visibility for GATC Health as decision-makers convene to discuss challenges and chart the future of the industry. 

Tune in Tuesday, November 18, to watch Dr. Gupta’s presentation

Dr. Gupta’s remarks will address national trends in affordability and access and provide an update on GATC Health’s ongoing work, including the Derisq™ AI Report. Like a FICO® Score for drug discovery and development, the Derisq™ AI Report by GATC Health delivers objective, AI-powered insights that help biotech leaders and investors prioritize assets and predict outcomes – all before committing capital or entering the clinic.

By highlighting persistent frustrations around rising premiums, out-of-pocket expenses, and hospital, physician, and pharmaceutical costs, he will make the case for innovative solutions. Dr. Gupta will also amplify a critical but under-discussed issue: how outdated drug discovery systems inflate development costs and slow the adoption of breakthrough therapies—a challenge GATC is uniquely positioned to address. 

The forum will convene leading voices from across healthcare, including Meena Seshamani, M.D., Ph.D. (Maryland Secretary of Health), Rep. Becca Balint (D-VT), Jonathan Burks (Bipartisan Policy Center), Shelley Lyford (West Health), Joe Daly (Gallup), and others. 

Programming: Tuesday, November 18, from 9:15 a.m. to 11:30 a.m. EDT with Dr. Gupta’s main-stage remarks scheduled for approximately 11:00am EDT. 

Watch the event live here.

About GATC Health

GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.